This opportunity is no longer accepting applications.
grant RFA-DA-26-018

Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional)

This grant opportunity focuses on researching new and emerging drug threats like xylazine and nitazenes, which are appearing in the drug supply. It emphasizes the need to analyze real-world drug samples, noting that while testing strips are commonly used for known drugs due to their efficiency and accuracy, new threats may not have such strips available. Therefore, the research must utilize se…

Emerging threats continuously evolve. Xylazine, nitazenes, and other future threats are making their way or are already in the drug supply. Understanding them requires analyzing real world samples. Typically, testing strips are used to detect drug for which such strip exists, as the strips are f…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: November 4, 2024
Open for Submission: November 4, 2024
Submission Deadline: February 19, 2025
Application Window Closes: February 19, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.